Fast Money's ASCO Biotech Trades
3021 views
Rate Now:
average rating: 0.00 / 0 ratings
Created by barrons2
DESCRIPTION:
Date updated:05-29-2008
The biotech sector is anticipating a big weekend for cancer drugs in the ASCO conference. What is the trade?
-
IMCL
N/a - $69.67
- 0.00
- $69.67
We’re talking about lung cancer, explains CNBC Pharmaceuticals Reporter Mike Huckman. Look for headline-grabbing test results out of ImClone (IMCL).
-
DNA
N/a - $80.43
- 0.00
- $80.43
Also keep an eye on Genetech (DNA), he says for two reasons 1) because the lung cancer data could have an impact on one of their drugs and Genentech should also deliver news on a breast cancer treatment.
-
LLY
Lilly Eli Co - $36.59
- +1.30%
- $36.04
As well as more details from Eli Lilly (LLY) on Alimta, its drug for lung cancer.
-
CELG
Celgene Corporati - $54.91
- +0.66%
- $54.42
In addition, Celgene (CELG) is another name to watch but keep in mind shares rallied when most of its study results were released two weeks ago.
-
BIIB
Biogen Idec Inc - $46.38
- +1.16%
- $45.56
As well as Biogen (BIIB) and Elan (ELN).
-
ELN
Elan Cp Plc Adr - $6.46
- -2.71%
- $6.56
As well as Biogen (BIIB) and Elan (ELN).
- Top Professional Portfolios
- 1. Fidelity Contrafund - ...
- 2. Navellier & Associ...
- 3. Calamos Advisors
- 4. Argus Management
- 5. Bernard L. Madoff Inve...
- show all
- Top Do-It-Yourself Portfolios
- » Joseph Russell Portfolio 1
- » Albo's First Portfolio
- » Darrell Werth Portfolio 1
- » Echo5Joker's Portfolio
- » jgroov Portfolio 1
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- » Renaissance Technologies
- show all
Cramer's Take on Headline Stocks...
Not a Stockpickr member? Join the community today -- for free.Regardless of why a stock is in the news, it never hurts to hear what a professional investor has to say about...
11.20.09 | 11:48 AM
Jim Cramer's Portfolios of the Week
By Roberto Pedone Posted on Nov. 20, 2009 According to Jim Cramer, options expiration is driving the current market selloff. He pointed out that the only stocks that we...
11.20.09 | 08:09 AM
'Fast Money' Portfolios of the Week
By Roberto Pedone Posted on Nov. 19, 2009 According to CNBC’s “Fast Money” traders, the stock market is showing no signs of stopping its current bull run. Joe Ter...
11.19.09 | 11:13 AM
Squeezing the Shorts: Earnings G...
more articles
By Jonas Elmerraji Posted on Nov. 18, 2009 There are plenty of reasons for stocks to have the attention of short-sellers. Waning financials, a deteriorating business mo...
11.18.09 | 12:36 PM
The Presidential/Political Thread
01.02.08 | 08:05 AM From author
Dave Cox
General market Technical Analysi...
11.14.07 | 22:55 PM From author
ZA
What happened to SPRD this week?
11.21.09 | 19:28 PM From author
xdhong
possible environmental problems ...
more forums
11.21.09 | 16:40 PM From author
fine tune your disciplines
Q.
If Goldman Sachs is stupid, what...
11.21.09 | 17:17 PM Asked by
Clementplace
A. Here's another one:
http://seekingalpha.com/article/173986-s
hipping-three-high-risk-high-reward-opti
ons
Also, DSX, for instance moved up after
hours.
It might depend on your timeframe. The
related indexes appear to be trending
up. (this is not a recommendation).
Q.
Steel....playing catch up now. ...
03.24.09 | 11:34 AM Asked by
dgbkr
A. The only one I own : SLX,
too hard pick a winner out all of them
today 's lists
Rising on Unusual Volume
Here are some stocks that moved up on unusual volume on Nov. 19, 2009. more
52-Week Highs
Here are some of the biggest stocks that made the 52-week high list on Nov. 20, 2009. more
Analyst Upgrades
Analyst Upgrades or Estimate Increases for Nov. 20, 2009. Read more here. more
Comments not available